single invest


GlycoDisplay develops novel biopharmaceuticals by modifying sugars.

GlycoDisplay has been a part of the Accelerace accelerator program, that help startup companies accelerate and scale up their business model and finetune their companies. GlycoDisplay is one of more than 500 companies that Accelerace already have accelerated.

Related startups